• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Arthritis Research U.K., MS Society to award $10 million in research grants

Arthritis Research U.K., MS Society to award $10 million in research grants

September 6, 2013
CenterWatch Staff

Arthritis Research U.K. and the MS Societyare partnering three research councils in the second stage of a nationwide project, which will see $10 million made available to researchers in stem cell and tissue engineering research.

Regenerative medicine is the process of replacing or regenerating damaged or diseased tissue so normal function can be restored without joint replacement surgery.

The $39 million U.K. Regenerative Medicine Platform (UKRMP) aims to address the challenges associated with translating scientific discoveries into patient benefit in the field of regenerative medicine.

The first stage led to the creation of several interdisciplinary research centers set up to address some of the scientific questions that block new therapies from being translated into new treatments for patients.

Now the research councils are inviting research proposals to establish collaborative research groupings to build on the success of the initial funding and stimulate research with the potential to become new regenerative medicine treatments.

“We hope that by being involved in this initiative, we will stimulate a number of opportunities to bring together leading scientists to tackle the necessary issues to bring these therapies into patients,” said Professor Alan Silman, medical director of Arthritis Research U.K.

Arthritis Research U.K. also has formed a collaboration with a European research body with the Dutch Arthritis Foundation, Rheumafonds. This collaboration follows recognition that there is some overlap between U.K. and Dutch research groups in the field of regenerative medicine and osteoarthritis.

Rheumafonds are now also involved in the UKRMP initiative, and will contribute financially to grant applications that can show added value for English and Dutch researchers working collaboratively.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing